Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well celecoxib works in preventing multiple
myeloma in patients with monoclonal gammopathy or smoldering myeloma. Chemoprevention therapy
is the use of certain drugs to try to prevent the development or recurrence of cancer. The
use of celecoxib may be effective in preventing multiple myeloma.